Article
Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
Expert review of molecular diagnostics - 1 Jan 2016
Kanagal-Shamanna Rashmi, Singh Rajesh R, Routbort Mark J, Patel Keyur P, Medeiros L Jeffrey, Luthra Rajyalakshmi
Abstract excerpt
Targeted therapy based on mutational profiles is the current standard of practice for the management of patients with hematologic malignancies. Next-generation sequencing (NGS)- based analysis has been adopted by clinical laboratories for high-throughput mutational profiling of myeloid and lymphoid neoplasms. The technology is fairly novel and complex, hence both validation and test implementation in a...
Topics
Join the communities discussing this publication.
